/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

style
pb-0

Amarin Corp PLC

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0
$16.29 0.0489(4.89%) AMRN at 04 Dec 2025 04:25 PM Drug Manufacturers - General
Lowest Today 15.62
Highest Today 16.23
Today’s Open 15.62
Prev. Close 15.53
52 Week High 20.90
52 Week Low 7.00
Day’s Range: Low 15.62 High 16.23
52-Week Range: Low 7.00 High 20.90
1 day return -
1 Week return +1.37
1 month return +6.9
3 month return +8.26
6 month return +37.59
1 year return +3150.0
3 year return +1277.11
5 year return +223.7
10 year return -

Institutional Holdings

Sarissa Capital Management LP 6.01

Kynam Capital Management, LP 2.79

Eversept Partners, LLC 0.81

Morgan Stanley - Brokerage Accounts 0.79

SCP Investment, LP 0.60

Waterfront Wealth Inc. 0.46

Waterfront OE 0.37

BNP Paribas Arbitrage, SA 0.37

Two Sigma Investments LLC 0.29

Quinn Opportunity Partners LLC 0.28

Hayek Kallen Investment Management 0.25

PSM Value Strategy UI 0.24

Citadel Advisors Llc 0.22

Millennium Management LLC 0.22

Waterfront OS 0.22

LCM Capital Management, Inc 0.21

Susquehanna International Group, LLP 0.21

Jump Financial LLC 0.19

George Kaiser Family Foundation 0.18

Trexquant Investment LP 0.16

SEI Investments Co 0.14

Resources Investment Advisors Inc 0.13

Bleakley Financial Group LLC 0.11

Old Westbury Small & Mid Cap Strategies 0.09

Fidelity Nasdaq Composite Index 0.08

SPDR® Portfolio Developed Wld ex-US ETF 0.07

iShares Nasdaq US Biotech ETF USD Acc 0.06

SEI International Equity F (SIT) 0.06

PSM Macro Strategy 0.05

Macquarie Healthcare I 0.05

Voya Multi-Manager International Sm Cp A 0.03

SPDR® S&P® International Small Cap ETF 0.03

Acadian All Ctry Wld ex US SCap Eq CL A 0.03

Acadian European SmCp Eq C2-i-0.7500-EUR 0.02

China Universal NASDAQ Bio-Tch ETF(QDII) 0.02

Hector SICAV FIDE Growth 0.02

PSM Dynamik 0.01

Blackstone Alternative Multi-Strategy I 0.01

Steward Values Enhanced International I 0.01

Daiwa NASDAQ Biotech Index Mother Fund 0.00

Market Status

Strong Buy: 0

Buy: 0

Hold: 1

Sell: 2

Strong Sell: 0

Fundamentals

Market Cap 322.91 M

PB Ratio 0.7077

PE Ratio 0.0

Enterprise Value 44.93 M

Total Assets 685.35 M

Volume 66154

Company Financials

Annual Revenue FY23:322443000 322.4M, FY22:369193000 369.2M, FY21:583187000 583.2M, FY20:614060000 614.1M, FY19:429755000 429.8M

Annual Profit FY23:184021000 184.0M, FY22:242484000 242.5M, FY21:461860000 461.9M, FY20:482616000 482.6M, FY19:333736000 333.7M

Annual Net worth FY23:-52475000 -52.5M, FY22:-105803000 -105.8M, FY21:7729000 7.7M, FY20:-18000000 -18.0M, FY19:-22645000 -22.6M

Quarterly Revenue Q3/2025:48558000 48.6M, Q2/2025:72741000 72.7M, Q1/2025:42017000 42.0M, Q3/2024:42298000 42.3M, Q2/2024:67566660 67.6M

Quarterly Profit Q3/2025:22208000 22.2M, Q2/2025:50362000 50.4M, Q1/2025:25130000 25.1M, Q3/2024:16276000 16.3M, Q2/2024:42055093 42.1M

Quarterly Net worth Q3/2025:-7738000 -7.7M, Q2/2025:-14139000 -14.1M, Q1/2025:-15697000 -15.7M, Q3/2024:-25134000 -25.1M, Q2/2024:1522000 1.5M

Fund house & investment objective

Company Information Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally through wholesalers, selected regional wholesalers, and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin 2, Ireland.

Organisation Drug Manufacturers - General

Employees 275

Industry Drug Manufacturers - General

CEO Mr. Aaron D. Berg

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow